Study of Bioavailability, Pharmacodynamics and Safety of SHR-1209 Administered by Single Subcutaneous Injection at Different Sites in Healthy Volunteers

NCT05370950 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

159

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia and Hyperlipidemia

Interventions

DRUG: SHR-1209

Sponsor

Jiangsu HengRui Medicine Co., Ltd.